See also this year's filing and all EDGAR filings for this company.
PDF Report 0001851194_2022_Ventyx_Biosciences_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 11, '100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) 2': 3}} |
Graph
Absolute values for 0001851194, Ventyx Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 263,020,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 254,000 |
| 3 | remainder_Assets | 28,208,000 |
| 4 | LiabilitiesCurrent | 12,283,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,666,000 |
| 9 | ResearchAndDevelopmentExpense | 58,481,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -16,599,000 |
| 13 | remainder_ComprehensiveNetIncome | -58,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 291,482,000 |
| 1 | Liabilities | 12,283,000 |
| 2 | Expenses | 67,147,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 279,199,000 |
| 5 | NetIncome | -83,746,000 |
| 6 | ComprehensiveNetIncome | -83,775,000 |
| 7 | BaseVar | 193,784,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.46 |
| 9 | EconomicCapitalRatio | 4.00 |
Edgar->Model Mapping
Feature Distribution
